INS and type 1 diabetes mellitus: In a study comparing continuous subcutaneous insulin infusion (CSII) and multiple injections of insulin in type 1 diabetes, although glycemic control was similar among the two treatment groups after 24 months, improvements were observed in CNFL, CNFD, and CNBD only in the CSII group [24].